Physiomics Plc
Physiomics Plc provides consulting services to pharmaceutical companies in the areas of outsourced quantitative pharmacology and computational biology in the United Kingdom, the United States, and the European Union Switzerland. The company offers modeling, simulation, and data analysis services covering various ranges of oncology research and development using its proprietary Virtual Tumour pred… Read more
Market Cap & Net Worth: Physiomics Plc (PYC)
Physiomics Plc (LSE:PYC) has a market capitalization of $15.68K (GBX128.86 Million) as of March 18, 2026. Listed on the LSE stock exchange, this UK-based company holds position #49886 globally and #1434 in its home market, demonstrating a -5.56% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Physiomics Plc's stock price GBX0.43 by its total outstanding shares 303208718 (303.21 Million).
Physiomics Plc Market Cap History: 2015 to 2026
Physiomics Plc's market capitalization history from 2015 to 2026. Data shows change from $129.12K to $15.68K (-21.79% CAGR).
Index Memberships
Physiomics Plc is a constituent of 1 market index:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
FTSE AIM All Share Index
FTAI
|
$41.09 Million | 0.00% | #376 of 722 |
Weight: Physiomics Plc's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Physiomics Plc Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Physiomics Plc's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.01x
Physiomics Plc's market cap is 0.01 times its annual revenue
1728.56x
Lower than industry averageLatest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $71.94K | $297.12K | -$378.70K | 0.24x | N/A |
| 2017 | $299.75K | $270.46K | -$400.53K | 1.11x | N/A |
| 2018 | $140.19K | $512.90K | -$183.34K | 0.27x | N/A |
| 2019 | $127.28K | $783.10K | -$104.04K | 0.16x | N/A |
| 2020 | $271.15K | $799.05K | -$64.42K | 0.34x | N/A |
| 2021 | $239.80K | $702.31K | -$215.83K | 0.34x | N/A |
| 2022 | $105.14K | $830.27K | -$253.14K | 0.13x | N/A |
| 2023 | $59.03K | $597.35K | -$477.26K | 0.10x | N/A |
| 2024 | $27.67K | $543.25K | -$609.35K | 0.05x | N/A |
| 2025 | $10.51K | $784.00K | -$415.25K | 0.01x | N/A |
Competitor Companies of PYC by Market Capitalization
Companies near Physiomics Plc in the global market cap rankings as of March 18, 2026.
Key companies related to Physiomics Plc by market ranking:
- Vertex Pharmaceuticals Inc (NASDAQ:VRTX): Ranked #162 globally with a market cap of $117.09 Billion USD.
- Regeneron Pharmaceuticals Inc (NASDAQ:REGN): Ranked #281 globally with a market cap of $74.80 Billion USD.
- CSL Limited (PINK:CMXHF): Ranked #344 globally with a market cap of $63.46 Billion USD.
- argenx SE (OTCGREY:ARGNF): Ranked #500 globally with a market cap of $42.99 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #162 | Vertex Pharmaceuticals Inc | NASDAQ:VRTX | $117.09 Billion | $462.49 |
| #281 | Regeneron Pharmaceuticals Inc | NASDAQ:REGN | $74.80 Billion | $759.05 |
| #344 | CSL Limited | PINK:CMXHF | $63.46 Billion | $149.87 |
| #500 | argenx SE | OTCGREY:ARGNF | $42.99 Billion | $697.42 |
Physiomics Plc Historical Marketcap From 2015 to 2026
Between 2015 and today, Physiomics Plc's market cap moved from $129.12K to $ 15.68K, with a yearly change of -21.79%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | GBX15.68K | +49.12% |
| 2025 | GBX10.51K | -62.00% |
| 2024 | GBX27.67K | -53.12% |
| 2023 | GBX59.03K | -43.86% |
| 2022 | GBX105.14K | -56.15% |
| 2021 | GBX239.80K | -11.56% |
| 2020 | GBX271.15K | +113.04% |
| 2019 | GBX127.28K | -9.21% |
| 2018 | GBX140.19K | -53.23% |
| 2017 | GBX299.75K | +316.67% |
| 2016 | GBX71.94K | -44.29% |
| 2015 | GBX129.12K | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of Physiomics Plc was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $15.68K USD |
| MoneyControl | $15.68K USD |
| MarketWatch | $15.68K USD |
| marketcap.company | $15.68K USD |
| Reuters | $15.68K USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.